Free tool
FAERS Monitor: Hydromorphone Hydrochloride
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 217812 or its brand name (Hydromorphone Hydrochloride, Hydromorphone Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
12,457
Serious
11,594
93% of reports
Hospitalization
3,471
Death reported
2,862
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug dependence2,688
- pain2,511
- drug ineffective2,127
- off label use1,893
- overdose1,828
- nausea1,796
- drug hypersensitivity1,720
- vomiting1,560
- headache1,473
- fatigue1,312
- dyspnoea1,213
- pneumonia1,193
- asthma1,174
- malaise1,111
- drug intolerance1,071
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 43 |
| 2005 | 39 |
| 2006 | 43 |
| 2007 | 45 |
| 2008 | 41 |
| 2009 | 37 |
| 2010 | 97 |
| 2011 | 20 |
| 2012 | 114 |
| 2013 | 55 |
| 2014 | 60 |
| 2015 | 111 |
| 2016 | 215 |
| 2017 | 309 |
| 2018 | 863 |
| 2019 | 1,007 |
| 2020 | 846 |
| 2021 | 1,746 |
| 2022 | 2,409 |
| 2023 | 1,232 |
| 2024 | 1,392 |
| 2025 | 1,077 |
| 2026 | 655 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,702 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug dependenceSignal | 2,688 | 28.7 | 27.7 | 71,150 |
| drug intoleranceSignal | 1,071 | 18.9 | 17.9 | 18,039 |
| asthmaSignal | 1,174 | 17.7 | 16.8 | 18,404 |
| drug hypersensitivitySignal | 1,720 | 15.1 | 14.5 | 22,694 |
| overdoseSignal | 1,828 | 14.4 | 13.8 | 22,862 |
| painSignal | 2,511 | 6.9 | 6.7 | 13,055 |
| pneumoniaSignal | 1,193 | 6.2 | 5.9 | 5,308 |
| vomitingSignal | 1,560 | 5.6 | 5.4 | 6,032 |
| malaiseSignal | 1,111 | 4.3 | 4.1 | 2,847 |
| headacheSignal | 1,473 | 4.0 | 3.8 | 3,368 |
| nauseaSignal | 1,796 | 3.8 | 3.7 | 3,904 |
| off label useSignal | 1,893 | 3.7 | 3.5 | 3,800 |
| dyspnoeaSignal | 1,213 | 3.6 | 3.4 | 2,360 |
| fatigueSignal | 1,312 | 2.8 | 2.7 | 1,630 |
| drug ineffectiveSignal | 2,127 | 2.7 | 2.6 | 2,477 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.